Federal IDR outcomes: Intraoperative neuromonitoring in New York
In 2025 Q1–Q4, the provider or facility offer prevailed in 85.1% of 8,556 determined Federal IDR dispute line items for intraoperative neuromonitoring in New York. The median prevailing offer was 27.76x the QPA (25th–75th percentile 7.21x–81.94x; n = 6,106). The median time to a decision was 43 business days (n = 8,556).
Determined line items
8,556
2025 Q1–Q4 · 8 split decisions excluded
Provider win rate
85.1%
n = 8,556 · 2025 Q1–Q4
Median days to decision
43
business days, from dispute initiation · n = 8,556 · 2025 Q1–Q4
Dollar amounts are not shown for specialty groups: the CMS QPA and Offers file, the only source of dollar figures, has no specialty field. See methodology.
By period
| Period | Line items | Win % | Median ×QPA | 25th–75th | Ratio n | Median days |
|---|---|---|---|---|---|---|
| 2025 Q1–Q4 | 8,556 | 85.1% | 27.76x † | 7.21x–81.94x | 6,106 | 43 |
| 2024 Q1–Q4 | 5,509 | 86.4% | 26.30x † | 8.27x–72.24x | 4,313 | 90 |
| 2023 Q1–Q4 | 746 | 78.7% | 24.84x † | 4.75x–69.86x | 585 | 91 |
| 2023 Q1–2025 Q4 | 14,811 | 85.3% | 26.82x † | 7.45x–77.62x | 11,004 | not pooled |
Line items = determined dispute line items (n). Win rate excludes split decisions and includes default decisions. Ratio n = line items reporting a payment-to-QPA ratio. Days are business days as reported by CMS (2023–2024: from IDR entity assignment; 2025: from initiation) and are never pooled.
Most disputed CPT codes
| CPT code | Line items | Win % | Median ×QPA | Ratio n | Median days |
|---|---|---|---|---|---|
| 95938 Placement of skin electrodes and measurement of stimulated sites on arms and leg | 2,300 | 85.4% | 84.18x † | 1,671 | 41 |
| 95939 Placement of skin electrodes and measurement of central motor stimulation in arm | 1,122 | 86.4% | 39.04x † | 782 | 43.5 |
| 95941 Continuous remote monitoring of nervous system during operation, each hour | 1,033 | 87.1% | 15.73x | 669 | 38 |
| 95861 Needle measurement of electrical activity in arm or leg muscles, 2 extremities | 846 | 86.2% | 26.00x † | 661 | 39 |
| 95937 Testing of nerve-muscle junction | 786 | 86.0% | 38.80x † | 472 | 39 |
| 95870 Needle measurement of electrical activity in arm, leg, trunk or head muscles, li | 672 | 86.2% | 40.57x † | 467 | 45.5 |
| 95955 Measurement of brain wave activity (EEG) outside the brain during surgery | 148 | 84.5% | 44.83x † | 103 | 73 |
| 95940 Continuous monitoring of nervous system during operation, each 15 minutes | 125 | 80.0% | 20.90x † | 120 | 51 |
| 95812 Measurement of brain wave activity (EEG), 41-60 minutes | 97 | 77.3% | 10.36x | 49 | 32 |
| 95885 Needle measurement of electrical activity in arm or leg muscles, limited study | 59 | 83.1% | 17.30x | 54 | 46 |
| 95999 Other diagnostic neurological or neuromuscular procedure | 55 | 83.6% | – | 19 | 120 |
| 95867 Needle measurement of electrical activity in muscles on side of body | 50 | 86.0% | 19.51x | 31 | 48 |
| 95907 Nerve conduction, 1-2 studies | 44 | 79.5% | 34.87x † | 41 | 35.5 |
| 51785 Needle measurement and recording of electrical activity of muscles at bladder an | 41 | 95.1% | 25.41x † | 39 | 51 |
| 95908 Nerve conduction, 3-4 studies | 41 | 87.8% | 11.78x | 38 | 72 |
| 95886 Needle measurement of electrical activity in arm or leg muscles, complete study | 40 | 85.0% | 37.58x † | 32 | 75 |
| 95822 Measurement of brain wave activity (EEG), in coma or asleep | 35 | 97.1% | – | 20 | 50 |
| 95720 Measurement of brain wave activity with video (VEEG), 12-26 hours with review an | 34 | 88.2% | – | 20 | 61 |
| 95868 Needle measurement of electrical activity in muscles on both sides of body | 30 | 86.7% | – | 19 | 38 |
2025 Q1–Q4 · rows with n ≥ 30 determined line items · sorted by n.
Related: all specialties in New York · Intraoperative neuromonitoring in all states
FAQ
What is the Federal IDR provider win rate for intraoperative neuromonitoring in New York?
In 2025 Q1–Q4, the provider or facility offer was selected in 85.1% of 8,556 determined dispute line items for intraoperative neuromonitoring in New York. Split decisions are excluded from the denominator and default decisions are included. Withdrawn, settled and ineligible disputes are not in the CMS data.
How do Federal IDR payments compare with the QPA for intraoperative neuromonitoring in New York?
In 2025 Q1–Q4, the median prevailing offer was 27.76x the qualifying payment amount (QPA), with a 25th to 75th percentile range of 7.21x to 81.94x (n = 6,106 line items). This uses the CMS field Prevailing Party Offer as % of QPA, where 1.00x equals the QPA.
How long do Federal IDR decisions take for intraoperative neuromonitoring in New York?
In 2025 Q1–Q4, the median was 43 business days (n = 8,556 line items), using the CMS field Length of Time to Make Determination (from dispute initiation).